Authors: Mattia, Consalvo¹; Coluzzi, Flaminia²

Source: Expert Opinion on Pharmacotherapy, Volume 7, Number 13, September 2006 , pp. 1811-1823(13)

Publisher: Informa Healthcare

Abstract:

New once-daily formulations of tramadol have been recently marketed in various countries. This review focuses on the matrix systems used in sustained-release formulations to control drug delivery, the pharmacokinetics and pharmacodynamic profile and the available clinical trials on once-daily tramadol. Four controlled clinical studies with a limited number of patients have shown that once-daily tramadol is safe and effective for up to 12 weeks in rheumatological pain treatment, with a favourable side effects profile. Once-daily tramadol has established efficacy superior to that of placebo for pain management and functional improvement in patients with osteoarthritis. Two randomised clinical trials demonstrated similar rates of efficacy between immediate-release and once-daily sustained-release formulation, without significant differences in the use of escape medications and the number of nights woken. Once-daily tramadol offers the advantage of a reduced dosing regimen that improves patient compliance.

Keywords: low-back pain; once-daily tramadol; osteoarthritis; rheumatological pain; sustained release; tramadol

Document Type: Drug Evaluation

DOI: http://dx.doi.org/10.1517/14656566.7.13.1811

Affiliations: 1: 1Associate Professor in Anaesthesiology and Intensive Care Medicine, Department of Anaesthesia, Intensive Care Medicine and Pain Therapy, University `La Sapienza' - Roma, Via Vaglia 25 00139 Roma , Italy., Email: consalvo.mattia@uniroma1.it 2: 2Assistant Professor in Anaesthesiology and Intensive Care Medicine, Department of Anaesthesia, Intensive Care Medicine and Pain Therapy, University `La Sapienza' - Roma, Viale del Polclinicio 166, 00161 Roma, Italy

Publication date: 2006-09-01

More about this publication?

• Editorial Board
• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Mattia, Consalvo ;  Coluzzi, Flaminia

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers